The 2013 National Inpatient Sample suggests that 85% of carotid patients undergo carotid endarterectomy (CEA) while 15% undergo transfemoral carotid artery stenting (TF-CAS), many of whom are at high risk for complications from CEA. 1 Outcomes of carotid revascularization in patients at high risk for surgery by Centers for Medicare and Medicaid criteria were analyzed in over 10,000 patients from the Society for Vascular Surgery Vascular Registry. 2 The 30-day stroke/death rates in high and standard risk, symptomatic and asymptomatic patients treated with CEA and TF-CAS are presented in Table I . High-risk patients undergoing TF-CAS fared worse than those undergoing CEA, regardless of symptomatic status. TF-CAS did not meet the intersocietal guidelines for 30-day stroke/death rates in symptomatic or asymptomatic cohorts (6% and 3%, respectively). 3 Neither did CEA meet these criteria in high surgical risk group. High-risk patients requiring carotid revascularization constitute an unmet clinical need. 2 Transcarotid artery revascularization (TCAR) provides a less invasive option than CEA and can match the stroke hazard of CEA in standard risk populations based on the pivotal Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure (ROADSTER) data. 4 The ROADSTER study of high-risk patients undergoing TCAR achieved a 30-day stroke rate of 1.4% in the pivotal cohort, the lowest to date for any prospective trial of endovascular carotid intervention. 4 The aim of this study is to provide specific technical details of TCAR, including tips and tricks for interventionalists using the device.
ANATOMIC CONSIDERATIONS
While relatively few patients present with anatomic characteristics such as restenosis post-CEA, neck irradiation, radical neck dissection, and cervical spine immobility, TCAR is not precluded by these anatomic challenges. In the ROADSTER Study, 36% of enrolled patients had prior neck dissection, irradiation, or both, and they still did very well with only one transient cranial nerve injury (0.7%) and no reports on poor wound healing. 4 Preoperative imaging is essential for patient selection and access site evaluation and can be done by duplex ultrasound imaging or computed tomography angiography of the neck vessels.
PATIENT PREPARATION
The periprocedural drug regimen has been previously described and includes dual antiplatelet therapy with aspirin and clopidogrel as well as beta-blockers and statins. 5, 6 TCAR can be performed under local or general anesthesia. There is no effective regional block for the cervical anatomy that will be exposed, and injection of a local anesthetic/epinephrine mixture is sufficient. An anesthesiologist should be in attendance to manage hemodynamic changes. A radial arterial line is helpful for continuous blood pressure monitoring to avoid hypotension/bradycardia, which impacts flow reversal and collateral flow (and potentially tolerance). Target systolic blood pressure is 140 to 160 mm Hg. Use of prophylactic atropine/glycopyrrolate and vasopressors/antihypotensive might be needed based on patients' hemodynamics. The patient is placed supine with the head in the same position used for CEA. It is useful to bring the C-arm for the fluoroscopy from the patient's head side with the surgeon standing on the right side of the patient and the assistant on the left side.
INTERVENTIONAL TECHNIQUE
Exposure of the common carotid artery. The primary anatomic landmark is the triangle created by the sternal and clavicular heads of the sternocleidomastoid muscle and the superior edge of the clavicle (Fig 1) . A longitudinal or transverse 2-to 4-cm incision is made between heads of the sternocleidomastoid muscle. Dissection should remain proximal to the omohyoid muscle and is largely avascular. The right common carotid artery (CCA) is usually more superficial than the left and sometimes overlays the recurrent laryngeal nerve from lateral to medial. Following longitudinal division of the carotid sheath, the jugular vein is partially dissected and retracted medially. The vagus nerve generally lies lateral and posterior to the CCA and is often not seen, but occasionally has an anterior course. A 3-to 4-cm segment of the proximal CCA is dissected circumferentially and umbilical tape with a Rummel tourniquet is placed as proximally as possible under direct vision. A purse string or U-stitch 5.0 polypropylene adventitial suture on the anterior surface of the CCA close to but not at the clavicle facilitates arterial closure at completion (Fig 2) .
Venous access. The femoral vein is accessed under ultrasound guidance, using a micropuncture system. The venous return sheath (VRS) is advanced over the 0.035 00 wire provided. Blood is aspirated from the flow line followed by flushing of the sheath with heparinized saline. The VRS should be secured with suture.
Arterial access. Lesion manipulation should be avoided prior to initiation of flow reversal. Heparin should be given to obtain an activated clotting time in the 250 to 300 seconds prior to arterial access. A 5F stiff micropuncture set is used, puncturing the artery through the previously placed purse string suture. The set includes a 0.035 00 Amplatz Super Stiff Wire with a 1-cm floppy tip (Boston Scientific, Marlborough, Mass). Gentle traction of the CCA with the umbilical tape loop provides essential stability to facilitate precise puncture and to avoid backwall penetration. The micropuncture wire is advanced 2-3 cm, the needle is removed, and the micropuncture sheath is advanced 1.5-2 cm into the CCA. Pulsatile backflow indicates correct positioning. Angiography through the microsheath with an oblique view helps delineate the bifurcation of the CCA and the location of the lesion. The 0.035 00 wire provided should be inserted as close as possible to the bifurcation without engaging the lesion. Alternatively, and if deemed safe in pure internal carotid artery lesions, the microwire and sheath can be advanced into the external carotid artery that allows the stiffer sheath wire to be placed into the external carotid artery. After micropuncture sheath removal, the arterial access sheath (AAS) is advanced to the 2.5-cm marker, a length predetermined by the sheath stopper (Fig 3) . Sheath position should be assessed under fluoroscopy in two projections to ensure the sheath tip is placed coaxially within the CCA. The sheath is sutured to the patient with gentle forward tension (Fig 3) . Additional fixation of the sheath to the anterior surface of the CCA can be obtained by traction on the purse string suture using a narrow soft rubber tourniquet. Blood is aspirated followed by flushing with heparinized saline. Slow aspiration avoids ingress of air bubbles through the passive hemostatic valve. The stopcocks are closed.
Initiation of flow reversal. The flow controller is connected to the AAS, prepared by passively allowing a column of arterial blood to fill the line and connected to the VRS (Fig 2) . The inflow to the CCA is occluded proximal to the arteriotomy with either gentle traction on the umbilical tape with a Rummel tourniquet or with an atraumatic vascular clamp. The flow controller has two flow settings and allows temporary cessation of flow via a flow stop button (FSB) for contrast injection (Fig 2) . Flow reversal is confirmed by two means. The first one consists of stopping the flow to the VRS with the stopcock then clearing the line by injecting heparinized saline. When the stopcock is opened, blood is seen returning in a reverse fashion from the flow controller to the VRS. The second way is by performing angiograms with slow gentle injection of a small amount of contrast to visualize just distal to the lesion while holding the FSB. Releasing the FSB confirms flow reversal in the artery.
Interventional procedure. Before crossing the lesion, systolic blood pressure should be managed upward to optimize flow reversal (140-160 mm Hg). Procedural steps are done through the AAS working channel. The ENROUTE transcarotid Neuroprotection System (NPS) has an inner diameter of 8F and an outer diameter of 10F. It is compatible with all U.S. Food and Drug Administrationapproved carotid stents including the ENROUTE transcarotid stent system (57-cm delivery system specifically designed and indicated for TCAR). The stent system is an open cell, laser-cute nitinol tube with a cell-free area of 5.89 mm 2 , a length of 20, 30, or 40 mm, and a diameter between 5 and 10 mm depending on vessel size. The close proximity to the lesion facilitates excellent crossing performance with 1:1 wire torque over a 0.014 00 wire. The type of 0.014 00 wire used is up to the operator. An angled tip catheter can be used to facilitate crossing of difficult lesions. TCAR access is less tortuous with fewer stored forces within the stent delivery system affording accurate stent deployment.
Cessation of flow reversal and sheath removal. Upon completion, antegrade flow is restored by releasing the loop on the CCA and closing the NPS stopcocks. The preclosure suture is tied as the AAS is removed without the need for vessel clamping. Heparin reversal and small drain placement are at the user's discretion. Hemostasis is achieved after removal of the femoral vein sheath with brief manual compression.
TIPS AND TRICKS
Neurologic intolerance. Although uncommon, neurologic intolerance to flow reversal may occur once the CCA is clamped and is usually manifested by confusion, agitation, or a slow decline in level of consciousness. A step-wise management plan is given in Table II .
AAS insertion.
Where the CCA is particularly deep, the AAS can make an acute bend over the clavicle as it enters the CCA. Various maneuvers can be tried in step-wise fashion to keep the sheath coaxial in the lumen (Table III) .
Avoiding nerve injury. Meticulous dissection will avoid neural structures. Vascular clamps on the CCA without direct vision should be avoided. Omohyoid should not be divided. Careful injection of local anesthetic is recommended as there have been limited reports of nerve injury because of local anesthetic infiltration into the nerve.
CONCLUSIONS
TCAR with the ENROUTE NPS and stent is a novel hybrid technique with the lowest reported CAS 30-day stroke rates in high-risk patients. Careful consideration of the technical aspects of the operation is essential for achieving successful outcomes with this procedure. Switching the flow controller to "Low" with continued monitoring of the patient and, if tolerated, alternating to high flow during key interventional steps (alternatively, the procedure can be completed on "Low" flow)
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Ischemic preconditioning: temporarily halting the procedure and re-establishing antegrade flow by releasing control of the CCA inflow for 5 minutes and then reclamping 5 Expeditious completion of the procedure on "High" flow (if there is no focal neurological deficit) 6 Convert to GA (lower cerebral metabolic demand) and complete expeditiously 7 If all above fails, the operator should consider abandoning flow reversal and employing a distal embolic protection filter.
GA, General anesthesia; CCA, common carotid artery. Table III .
Step-wise management of the insertion of the arterial access sheath (AAS)
Order of successive suggested step Suggested management 1 Serial dilatation of the arteriotomy with 6F then 8F dilators 2 Although the 0.035 00 guidewire should stop short of the bifurcation, engaging the external carotid artery with the 0.018 00 microwire and microsheath and exchanging for an extra-support wire provides superior wire purchase 3 Tunneling the AAS over the clavicle through a second dermatotomy caudal to the clavicle might provide a gentler entry angle into the CCA CCA, Common carotid artery.
